ROXALL is a pharmaceutical company focused on the development, production, and distribution of products in the field of allergology, immunology, and emergency medicine. It offers CLUSTO-Prick, a medical device for in-vivo diagnostic of allergic diseases, and PRIXI, an automated system for skin prick tests. In addition, the company provides pharmaceutical products for the therapy of poisoning emergencies (antidotes).